We are thrilled to be named “a firm to watch” by The Guardian. Undoubtedly, the success of our NASH studies this past year and the cutting-edge clinical trials we have planned for next year solidified our name on this list.
To read more, click here
2023 was a busy and productive year for Genflow Biosciences Plc (“Genflow) marked by significant advancements in our mission to pioneer novel therapeutics for a
Health Tech World has announced its Top 50 health tech innovators of 2022
Illness and chronic disease impact thousands of people every day. Many diseases are caused by genetic mutations, faulty genes, or cellular disruptions like cancer cells
Headquarters
Genflow Biosciences plc
6 Heddon Street
London
W1B 4BT
United Kingdom
Research and Development
Genflow Biosciences SRL
Biopark Gosselies
Rue Clément Ader, 10
B-6041 Charleroi
Belgium
US office address
Genflow Biosciences Inc
1050 Connecticut Avenue
Suite 500
Washington DC
20036, USA